These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 34298907)

  • 41. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
    Nakhate KT; Yedke SU; Bharne AP; Subhedar NK; Kokare DM
    Brain Res; 2016 Sep; 1646():1-11. PubMed ID: 27208493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligands of the neuropeptide Y Y2 receptor.
    Mittapalli GK; Roberts E
    Bioorg Med Chem Lett; 2014 Jan; 24(2):430-41. PubMed ID: 24365162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NPY mediates the feeding elicited by muscimol injections into the nucleus accumbens shell.
    Stratford TR; Wirtshafter D
    Neuroreport; 2004 Dec; 15(17):2673-6. PubMed ID: 15570176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions between NPY and CRF in the amygdala to regulate emotionality.
    Sajdyk TJ; Shekhar A; Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):225-34. PubMed ID: 15337374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Administration of neuropeptide Y into the rat nucleus accumbens shell, but not core, attenuates the motivational impairment from systemic dopamine receptor antagonism by α-flupenthixol.
    Carney AE; Clarke C; Pratt WE
    Neurosci Lett; 2023 Feb; 797():137069. PubMed ID: 36641044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor.
    Long M; Zhou J; Li D; Zheng L; Xu Z; Zhou S
    PLoS One; 2015; 10(5):e0126714. PubMed ID: 25993471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
    Henry M; Ghibaudi L; Gao J; Hwa JJ
    Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is there really an NPY Y3 receptor?
    Lee CC; Miller RJ
    Regul Pept; 1998 Sep; 75-76():71-8. PubMed ID: 9802395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor.
    Oki Y; Teraoka H; Kitazawa T
    Auton Autacoid Pharmacol; 2017 Mar; 37(2):23-28. PubMed ID: 28544313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
    Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
    Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-nociceptive effect of neuropeptide Y in the nucleus accumbens of rats: an involvement of opioid receptors in the effect.
    Li Y; Li JJ; Yu LC
    Brain Res; 2002 Jun; 940(1-2):69-78. PubMed ID: 12020877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell.
    Desai SJ; Upadhya MA; Subhedar NK; Kokare DM
    Behav Brain Res; 2013 Jun; 247():79-91. PubMed ID: 23511250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue.
    Shi YC; Baldock PA
    Bone; 2012 Feb; 50(2):430-6. PubMed ID: 22008645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the neuropeptide Y system in the frog Silurana tropicalis (Pipidae): three peptides and six receptor subtypes.
    Sundström G; Xu B; Larsson TA; Heldin J; Bergqvist CA; Fredriksson R; Conlon JM; Lundell I; Denver RJ; Larhammar D
    Gen Comp Endocrinol; 2012 Jul; 177(3):322-31. PubMed ID: 22565163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.
    Corder KM; Li Q; Cortes MA; Bartley AF; Davis TR; Dobrunz LE
    Neuropeptides; 2020 Feb; 79():101979. PubMed ID: 31708112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The NPY system in stress, anxiety and depression.
    Heilig M
    Neuropeptides; 2004 Aug; 38(4):213-24. PubMed ID: 15337373
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Y2 receptor mimetic aptamer directed against neuropeptide Y.
    Proske D; Höfliger M; Söll RM; Beck-Sickinger AG; Famulok M
    J Biol Chem; 2002 Mar; 277(13):11416-22. PubMed ID: 11756401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.